Melanotic neuroectodermal tumor of infancy (MNTI) of the hard palate: presentation and management

R Puchalski1, U K Shah, D Carpentieri

  • 1Division of Pediatric Otolaryngology, The Children's Hospital of Philadelphia, PA 19104-4399, USA.

Insights

Melanotic neuroectodermal tumor of infancy (MNTI) is a rare, benign hard palate tumor. Complete surgical excision is curative, but may require follow-up for palatal reconstruction and dental care.

Area of Science:

  • Oral pathology
  • Pediatric oncology
  • Developmental biology

Background:

  • Melanotic neuroectodermal tumor of infancy (MNTI) is a rare, benign, pigmented tumor of neural crest origin.
  • MNTI most commonly affects the maxilla, particularly the anterior hard palate in infants.
  • Early diagnosis and management are crucial for optimal outcomes.

Observation:

  • A 6-month-old female infant presented with a slow-growing, painless mass on the anterior hard palate.
  • Radiologic imaging demonstrated a well-circumscribed, cystic lesion containing unerupted teeth.
  • Histopathological and electron microscopic examination confirmed the diagnosis of MNTI.

Findings:

  • MNTI of the hard palate typically presents as a smooth, firm, painless, slow-growing lesion.
  • Imaging often reveals a well-circumscribed, cystic appearance, sometimes with calcifications or tooth-like structures.
  • Complete surgical excision is considered the definitive treatment for MNTI.

Implications:

  • Complete excision of MNTI generally leads to a favorable prognosis with no recurrence.
  • Management may necessitate multidisciplinary approaches, including plastic surgery for palatal reconstruction.
  • Long-term follow-up is important to address potential orthodontic needs and secondary nasal deformities.
Abstract